These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38219797)

  • 1. Preventing cognitive decline by reducing BP target (PCOT): A randomized, pragmatic, multi-health systems clinical trial.
    Giacona JM; Bates BM; Sundaram V; Brinker S; Moss E; Paspula R; Kassa S; Zhang R; Ahn C; Zhang S; Basit M; Burkhalter L; Cullum CM; Carlew A; Kelley BJ; Plassman BL; Vazquez M; Vongpatanasin W
    Contemp Clin Trials; 2024 Mar; 138():107443. PubMed ID: 38219797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study.
    BPROAD Study Group
    J Diabetes; 2023 Dec; 15(12):1041-1047. PubMed ID: 37737064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive withdrawal for the prevention of cognitive decline.
    Jongstra S; Harrison JK; Quinn TJ; Richard E
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011971. PubMed ID: 27802359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.
    Mouncey PR; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Lamontagne F; Rowan KM;
    Health Technol Assess; 2021 Feb; 25(14):1-90. PubMed ID: 33648623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Intensive vs Standard Blood Pressure Reduction and Association With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis.
    Dallaire-Théroux C; Quesnel-Olivo MH; Brochu K; Bergeron F; O'Connor S; Turgeon AF; Laforce RJ; Verreault S; Camden MC; Duchesne S
    JAMA Netw Open; 2021 Nov; 4(11):e2134553. PubMed ID: 34807261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control.
    Jiang C; Zhao M; Li M; Wang Z; Bai Y; Guo H; Li S; Lai Y; Wang Y; Gao M; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Sang C; Du X; Dong J; Anderson CS; Ma C
    J Intern Med; 2024 Apr; 295(4):557-568. PubMed ID: 38111091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
    Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
    J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    ; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
    JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
    Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
    JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.
    Haring B; Wu C; Coker LH; Seth A; Snetselaar L; Manson JE; Rossouw JE; Wassertheil-Smoller S
    Am J Hypertens; 2016 Feb; 29(2):202-16. PubMed ID: 26137952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.
    Jafar TH; Jehan I; de Silva HA; Naheed A; Gandhi M; Assam P; Finkelstein EA; Quigley HL; Bilger M; Khan AH; Clemens JD; Ebrahim S; Turner EL; ; Kasturiratne A
    Trials; 2017 Jun; 18(1):272. PubMed ID: 28606184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).
    Scutt P; Blackburn D; Krishnan K; Ballard C; Burns A; Ford GA; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw JM; Bath PM
    Trials; 2015 Nov; 16():509. PubMed ID: 26545986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
    Ryan J; Storey E; Murray AM; Woods RL; Wolfe R; Reid CM; Nelson MR; Chong TTJ; Williamson JD; Ward SA; Lockery JE; Orchard SG; Trevaks R; Kirpach B; Newman AB; Ernst ME; McNeil JJ; Shah RC;
    Neurology; 2020 Jul; 95(3):e320-e331. PubMed ID: 32213642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical analysis plan for the control of blood pressure and risk attenuation-rural Bangladesh, Pakistan, Sri Lanka (COBRA-BPS) trial: a cluster randomized trial for a multicomponent intervention versus usual care in hypertensive patients.
    Gandhi M; Assam PN; Turner EL; Morisky DE; Chan E; Jafar TH;
    Trials; 2018 Nov; 19(1):658. PubMed ID: 30486858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a pragmatic randomized implementation effectiveness trial testing a health system wide hypertension program for older adults.
    Gupta A; Chouhdry H; Ellis SD; Young K; Mahnken J; Comfort B; Shanks D; McGreevy S; Rudy C; Zufer T; Mabry S; Woodward J; Wilson A; Anderson H; Loucks J; Chandaka S; Abu-El-Rub N; Mazzotti DR; Song X; Schmitz N; Conroy M; Supiano MA; Waitman LR; Burns JM
    Contemp Clin Trials; 2024 Mar; 138():107466. PubMed ID: 38331381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing intervention for decreasing risk of developing dementia in elders with mild cognitive impairment: study protocol of a multicenter randomized controlled trial for Chinese Hearing Solution for Improvement of Cognition in Elders (CHOICE).
    Chen Y; Guan L; Chen J; Han K; Yu Q; Zhou J; Wang X; Ma Y; Ji X; Zhao Z; Shen Q; Wang A; Wang M; Li J; Yu J; Zhang Y; Xu S; Liu J; Lu W; Ye B; Fang Y; Hu H; Shi H; Xiang M; Li X; Li Y; Wu H
    Trials; 2023 Nov; 24(1):767. PubMed ID: 38017543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.